Autism is being treated successfully with regenerative therapy

Multiple university studies including Duke University Medical School have demonstrated safety and statistically significant improvement in autistic children.

Children and adults on the autism spectrum hold a special place in Dr. Weiss’s heart. His youngest son, Marston is on the autism spectrum and has received multiple doses of umbilical cord blood with tremendous results. Multiple studies demonstrate both functional and suggestive improvements in visual, emotional, and intellectual responses as well as in body use, adaptation to change, fear, nervousness, nonverbal communication, and activity level.

Assessment tools used to identify changes in behavior included: childhood autism rating scale, clinical global impressions, aberrant behavior checklist, expressive one-word picture vocabulary test, eye gaze tracking, pervasive developmental disability inventory, and Vineland Adaptive Behavior Scale II.

The most widely known study is the Duke University Medical Center study. 25 children (ages 4 to 6 years old) were given autologous umbilical cord blood as a single intravenous infusion. This study demonstrated that the procedure is safe and that most children demonstrated significant improvement in multiple areas. The ones that had the most improvement were the ones with the highest nonverbal IQ.

The phase II study from Duke is now recruiting patients and it will focus on the benefits of umbilical cord blood therapy versus stem cells recovered from the children’s bone marrow. The study has not started at this time.


A Special Testimonial

Dr. Weiss,